These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23410261)

  • 1. Topical anesthetic eye drops abuse: are we aware of the danger?
    Erdem E; Undar IH; Esen E; Yar K; Yagmur M; Ersoz R
    Cutan Ocul Toxicol; 2013 Sep; 32(3):189-93. PubMed ID: 23410261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical anesthetic abuse keratopathy: a commonly overlooked health care problem.
    Yagci A; Bozkurt B; Egrilmez S; Palamar M; Ozturk BT; Pekel H
    Cornea; 2011 May; 30(5):571-5. PubMed ID: 21598429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early amniotic membrane transplantation for toxic keratopathy secondary to topical proparacaine abuse: a report of seven cases.
    Burcu A; Dogan E; Yalniz-Akkaya Z; Ornek F
    Cutan Ocul Toxicol; 2013 Sep; 32(3):241-7. PubMed ID: 23360240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical findings in patients with topical anaesthetic abuse keratitis: a report of five cases.
    Katsimpris JM; Sarantoulakou M; Kordelou A; Petkou D; Petropoulos IK
    Klin Monbl Augenheilkd; 2007 Apr; 224(4):303-8. PubMed ID: 17458798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical anesthetic abuse.
    Rosenwasser GO; Holland S; Pflugfelder SC; Lugo M; Heidemann DG; Culbertson WW; Kattan H
    Ophthalmology; 1990 Aug; 97(8):967-72. PubMed ID: 2402423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxic keratopathy due to abuse of topical anesthetic drugs.
    Yeniad B; Canturk S; Esin Ozdemir F; Alparslan N; Akarcay K
    Cutan Ocul Toxicol; 2010 Jun; 29(2):105-9. PubMed ID: 20236030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity of topical ophthalmic anesthetics.
    Patel M; Fraunfelder FW
    Expert Opin Drug Metab Toxicol; 2013 Aug; 9(8):983-8. PubMed ID: 23617273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical anesthetic abuse ring keratitis: report of four cases.
    Varga JH; Rubinfeld RS; Wolf TC; Stutzman RD; Peele KA; Clifford WS; Madigan W
    Cornea; 1997 Jul; 16(4):424-9. PubMed ID: 9220240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical ocular anesthetic abuse: case report.
    Sun MH; Huang SC; Chen TL; Tsai RJ
    Chang Gung Med J; 2000 Jun; 23(6):377-81. PubMed ID: 10958042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical anesthetic abuse: a case report of bilateral corneal ring infiltrates.
    Rapuano CJ
    J Ophthalmic Nurs Technol; 1990; 9(3):94-5. PubMed ID: 2366253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ring Keratitis From Topical Anesthetic Abuse After Laser Epithelial Keratomileusis.
    Mergen B; Ozdamar A; Sarici AM
    Eye Contact Lens; 2018 Sep; 44 Suppl 1():S365-S367. PubMed ID: 28945650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subconjunctival bevacizumab for corneal neovascularization secondary to topical anesthetic abuse.
    Georgakopoulos CD; Vasilakis P; Makri OE; Beredima E; Pharmakakis N
    Cutan Ocul Toxicol; 2011 Dec; 30(4):320-2. PubMed ID: 21517719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical ocular anaesthetic abuse in a contact lens wearer: a case of microbial keratitis.
    Matti AI; Saha N
    Clin Exp Optom; 2012 Nov; 95(6):653-4. PubMed ID: 22621643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open clinical study of eye-drops containing tetrapeptides derived from substance P and insulin-like growth factor-1 for treatment of persistent corneal epithelial defects associated with neurotrophic keratopathy.
    Yamada N; Matsuda R; Morishige N; Yanai R; Chikama TI; Nishida T; Ishimitsu T; Kamiya A
    Br J Ophthalmol; 2008 Jul; 92(7):896-900. PubMed ID: 18511539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the tolerability and efficacy of unit-dose, preservative-free topical ocular anaesthetics.
    Lawrenson JG; Edgar DF; Tanna GK; Gudgeon AC
    Ophthalmic Physiol Opt; 1998 Sep; 18(5):393-400. PubMed ID: 10023471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous serum eyedrops in the treatment of aniridic keratopathy.
    López-García JS; Rivas L; García-Lozano I; Murube J
    Ophthalmology; 2008 Feb; 115(2):262-7. PubMed ID: 17675158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxic keratopathy associated with abuse of low-dose anesthetic: a case report.
    Chen HT; Chen KH; Hsu WM
    Cornea; 2004 Jul; 23(5):527-9. PubMed ID: 15220742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corneal complications of topical anesthetic abuse.
    Willis WE; Laibson PR
    Can J Ophthalmol; 1970 Jul; 5(3):239-43. PubMed ID: 5472832
    [No Abstract]   [Full Text] [Related]  

  • 19. Infectious crystalline keratopathy associated with topical anesthetic abuse.
    Kintner JC; Grossniklaus HE; Lass JH; Jacobs G
    Cornea; 1990 Jan; 9(1):77-80. PubMed ID: 2297999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical treatment with a new matrix therapy agent (RGTA) for the treatment of corneal neurotrophic ulcers.
    Aifa A; Gueudry J; Portmann A; Delcampe A; Muraine M
    Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8181-5. PubMed ID: 23150626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.